[144] Lennox International Inc. SEC Filing

Rhea-AI Filing Summary

Lennox International Inc. (LII) notice records a proposed sale of 300 common shares acquired by the holder through restricted stock vesting on 03/14/2025. The filer plans an approximate sale date of 08/22/2025 on the NYSE through Fidelity Brokerage Services LLC. The reported aggregate market value of the 300 shares at filing is $177,558.03 and total shares outstanding are shown as 35,124,281, indicating the transaction represents a very small fraction of the company’s outstanding common stock. The filing includes the seller’s representation that they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Clear compliance disclosure of intended Rule 144 sale with broker, date, and quantity specified
• Acquisition method disclosed: shares were acquired via restricted stock vesting and paid as compensation
• Aggregate value provided: the 300 shares are reported at $177,558.03, giving transparency on size

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR Routine Rule 144 notice for a small post-vesting sale; primarily a compliance disclosure.

The filing documents a planned sale under Rule 144 of 300 shares acquired via restricted stock vesting on 03/14/2025, to be executed through Fidelity on the NYSE around 08/22/2025. The aggregate market value reported is $177,558.03 and the issuer outstanding shares are listed as 35,124,281. This notice meets the regulatory requirement to disclose intended sales by an insider or restricted-holder and includes the standard attestation regarding undisclosed material adverse information.

Equity Capital Markets Analyst

TL;DR Transaction is immaterial to market cap and unlikely to affect trading or valuation.

At 300 shares versus 35,124,281 shares outstanding, the sale equals a de minimis portion of the float. The filing provides acquisition details (restricted stock vesting) and payment noted as compensation, which clarifies there is no purchase financing or gift involved. As a straightforward Rule 144 notice, it is procedural and not a material corporate event.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	300	177558.03	35124281	08/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/14/2025	Restricted Stock Vesting	Issuer			300	03/14/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for LII disclose?

The filing discloses a proposed sale of 300 common shares acquired by restricted stock vesting on 03/14/2025, to be sold around 08/22/2025 on the NYSE through Fidelity Brokerage Services LLC.

How much are the shares worth on the Form 144?

The aggregate market value reported for the 300 shares is $177,558.03.

How significant is the sale relative to Lennox International’s outstanding stock?

The filing lists 35,124,281 shares outstanding, so the 300-share sale is a very small fraction of outstanding common stock.

How were the shares acquired according to the filing?

The shares were acquired via restricted stock vesting on 03/14/2025 and the nature of payment is reported as compensation.

Does the filer assert any undisclosed material information?

Yes. By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.